Eora Health Messenger Spring 2024 Eora Health Messenger Spring 2024 is live now. This quarterly edition covers the following topics:
Review your pre-allocation for 2026 flu vaccines Measles alerts for Sydney Declining parental vaccine confidence: new national survey findings Maternal vaccines safe in twin pregnancies Education Review your pre-allocation for...
Vaccination across the lifespan: A comprehensive vaccination workshop Get prepared for 2026 flu vaccinations - review your pre allocation Measles alerts for Sydney Education Vaccination across the lifespan: A comprehensive...
Rising pertussis rates coincide with coverage drop in NSW Childhood immunisation coverage data Second season RSV doses for at-risk children Providing information about vaccination to linguistically diverse communities Education Rising pertussis...
Monitoring: Nipah Virus Detected Overseas Meningococcal Surveillance Report 2025 Measles alert for Sydney Education Monitoring: Nipah Virus Detected Overseas Two confirmed cases of Nipah virus infection have been reported in...
Summary of change From 1 July 2026, Capvaxive®, a new 21-valent pneumococcal conjugate vaccine (21vPCV), will be added to the National Immunisation Program (NIP). Capvaxive® will replace both Prevenar 13®...
Australia is experiencing its largest whooping cough (Pertussis) rise since surveillance began in 1991, with more than 82,000 cases recorded across 2024-25. Infants are the most vulnerable, especially those under...